Aug 11, 2020
Stephen M. Walker II and Guillaume D. Champeau, former Freeletics executives, announced today their human performance initiative named Unfair. Unfair reimagines the biohacking industry for a consumer audience by blending published science and AI technology with an engaging user experience.
The Unfair team began research and development while the COVID-19 pandemic swept the globe, operating in stealth mode until now. Unfair is a US-based startup with a globally distributed workforce. The startup quickly rose to prominence via the Pioneer startup accelerator, ranking in the top 10 startups and attracting investors from Los Angeles to Berlin. The Unfair mobile app launched in private beta in June, with thousands of users worldwide tracking their supplement intake. The Unfair team – now composed of the founders, doctors, scientists, and ML engineers – is developing their first commercial product, while conducting double-blind studies on a proprietary, data-informed supplement line.
The US performance supplementation market reached $11B in 2019, driven by consumers performing online health research. Despite the overwhelming interest in supplementation, over one-third of Americans are deficient in essential nutrients such as Vitamin D. Researchers found that 98.9% of COVID-19 patients with a Vitamin D deficiency died. The coronavirus pandemic emphasizes how difficult it is for consumers to know where to look, what information to trust, and what insights work to optimize their health. Online publications like nootropics guides to doctors on social media aim to solve this problem but often add to the different perspectives offered to consumers.
"Unfair is years in the making for both Guillaume and myself. We were guinea pigs developing the concepts that serve as the foundation of Unfair. We're now scaling this using a deep-learning neural network that analyzes physiological responses to activity, chemicals, and nutrition. We combine published scientific research with consumer-reported data and place it in your pocket." – Stephen M. Walker II, CEO
Before starting Unfair, Stephen and Guillaume met at Freeletics, where they led the Product and Brand Creative teams. While at Freeletics, they grew the Munich-based, mobile fitness company from profitably bootstrapped to over 40 million users worldwide. Stephen led the product vision to raise the $45M Series A in 2018 and expanded the business from fitness and nutrition into mindfulness with the introduction of Mindset Coaching in January 2020.
Visit Unfair.ltd today to sign up for early access.
About Unfair
Unfair is the world's first consumer biohacking company focused on combining published research and AI technology to provide their customers with an unfair advantage. Unfair develops a digital biohacking coach with supplementation intelligence and the first supplement line designed with millions of data points to increase focus, physical performance, and longevity. For more information, visit unfair.ltd.
Media Contact
Innovat Labs
Email: [email protected]
As Ukraine increasingly takes the war to Russia, the effects may be most visible on the roads.
China has called on G20 members to uphold multilateralism and strengthen cooperation, as trade ministers met in Milwaukee, USA, from September 30 to October 1 to discuss food security, industrial overcapacity, forced labor and the most-favored-nation principle.
Rising prices, weak spending put Japan's policymakers in tight spot
China's Ministry of Commerce said on Sunday that China played a constructive role at the G20 trade ministers' meeting, held in Milwaukee, the United States, from September 30 to October 1.
The film, starring Tom Cruise, grossed an estimated $8 million in its opening weekend. That could put the movie on track to lose at least $125 million.
Faced with bots immune to traditional marketing tactics, marketers are racing to win them over with logic and data.
China has started limiting exports of refined products again as its own inventories of crude oil and refined products have dwindled.
Fewer orders and higher costs are squeezing restaurants big and small as people on the weight-loss drugs eat and drink less when dining out.
The fiscal 2026 earnings cycle has underscored the extraordinary momentum behind the AI boom, with tech giants posting record revenues while their shares have also rallied. But beneath the headline numbers, a new test is emerging: how long can AI-driven cash generation keep pace with the massive investment required to expand computing capacity?
The president, who had hoped to tout a growing economy on the campaign trail, has found it hard to break through as workers’ wages fail to keep up.
Immediate action is needed to help households struggling with bills this winter, says trade body Energy UK.
Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.